Cite
32. QUALITY PERFORMANCE INDICATOR COMPLIANCE FOR THE TREATMENT OF OESOPHAGEAL ADENOCARCINOMA IN NEW ZEALAND.
MLA
Wang, Yijiao (Joanna), et al. “32. Quality Performance Indicator Compliance for the Treatment of Oesophageal Adenocarcinoma in New Zealand.” Diseases of the Esophagus, vol. 36, Sept. 2023, p. 1. EBSCOhost, https://doi.org/10.1093/dote/doad052.012.
APA
Wang, Y. (Joanna), Kulasegaran, S., Srinivasa, S., Koea, J., & Maccormick, A. (2023). 32. Quality Performance Indicator Compliance for the Treatment of Oesophageal Adenocarcinoma in New Zealand. Diseases of the Esophagus, 36, 1. https://doi.org/10.1093/dote/doad052.012
Chicago
Wang, Yijiao (Joanna), Suheelan Kulasegaran, Sanket Srinivasa, Jonathan Koea, and Andrew Maccormick. 2023. “32. Quality Performance Indicator Compliance for the Treatment of Oesophageal Adenocarcinoma in New Zealand.” Diseases of the Esophagus 36 (September): 1. doi:10.1093/dote/doad052.012.